Without a formal extension before the government shutdown, the flexible telemedicine reimbursement policies introduced in 2020 that removed regional barriers for Medicare patients have officially ended.

Healthcare's cost-conscious environment prompted the ACC and AHA to develop a statement on the value methodology to be used when creating clinical practice guidelines.

Martha Gulati, MD, co-chair on a new joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology, discusses the dire need she sees to boost prevention efforts for heart failure.

Yes, even frail HFpEF patients see significant benefits when treated with semaglutide. Researchers believe these new data may help ease the minds of cardiologists everywhere.

Cardiovascular disease remains the world’s leading cause of death, according to a special report from the American College of Cardiology. The new analysis, described by one cardiologist as a "wake-up call," includes data from more than 200 countries and territories.

TAVR reintervention rates remain low. However, they are slowly rising as the procedure is used more to treat patients with severe aortic stenosis. Researchers think this trend may continue going forward.

“It’s been a whirlwind,” Anders Gilberg, senior vice president of government affairs at MGMA, told HealthExec. “Rarely do we have an administration come in and do so much in such a short period of time.”

There have been so many developments in the treatment of TR that it can be challenging to keep up. The ACC crafted this new document to help ensure cardiologists, cardiac imagers and other clinicians have access to the most recent clinical data and policy decisions.